Core Viewpoint - Mingji Hospital, the largest private profit-oriented comprehensive hospital group in East China, faced a disappointing debut on the Hong Kong Stock Exchange, with its stock price plummeting 49.46% on the first day of trading, marking the worst opening for a new stock in Hong Kong in 2025 [1][14]. Group 1: Listing Journey - Mingji Hospital's IPO journey was marked by multiple challenges, including incomplete application materials and compliance risks, leading to delays in the listing process [5][16]. - The company finally succeeded in its fourth attempt to list on the Hong Kong Stock Exchange, becoming the fifth listed company from Nanjing in 2025 [5][16]. - The IPO raised approximately HKD 555 million, with cornerstone investors subscribing for a total of USD 39.9 million (about HKD 311 million) [5][16]. Group 2: Market Position - As of June 30, 2025, Mingji Hospital operates two hospitals with a total area of approximately 400,000 square meters and 1,850 registered beds [6][17]. - The hospital group ranked first among private profit-oriented comprehensive hospital groups in East China by bed revenue in 2024, with a market share of 1.0% regionally and 0.4% nationally [6][17]. Group 3: Financial Performance - Financial data indicates stagnation in growth, with revenues of CNY 2.336 billion, CNY 2.688 billion, and CNY 2.659 billion from 2022 to 2024, while net profit peaked at CNY 168 million in 2023 before declining to CNY 109 million in 2024 [8][19]. - In the first half of 2025, revenue dropped to CNY 1.312 billion, and net profit fell to CNY 49 million, a year-on-year decline of over 23% [9][20]. Group 4: Pricing and Market Perception - The IPO pricing strategy, which aimed to stabilize stock prices through a low public offering ratio, did not yield the desired results, with the stock price falling significantly post-IPO [10][21]. - The company's price-to-earnings (PE) ratio of 29.8 is considerably higher than that of comparable private hospital stocks, raising concerns about overvaluation [10][21]. Group 5: Use of Proceeds - The net proceeds from the IPO, approximately HKD 555 million, are allocated for hospital expansion and upgrades, with 74.3% designated for these purposes and 16% for potential investments and acquisitions [11][22]. - Plans include the construction of specialized centers in Nanjing and Suzhou hospitals, although the current bed occupancy rate is already high at 97.1% [11][22].

本报讯 （报业集团记者 杜正蓝） 近日，漳州市医院细胞治疗与再生医学中心揭牌仪式在漳州市医院总 部院区国际医疗中心举行。漳州市医院成为福建省首家正式挂牌成立"细胞治疗与再生医学中心"的三甲 医院。 该中心致力于推动细胞治疗与再生医学技术的临床转化与应用，对于提升区域医疗水平、加快国际医疗 中心建设具有积极推动作用，也将为区域康养文旅产业发展注入新的科技动能。 ...

（来源：南京晨报） 转自：南京晨报 "原本以为要跑大半天，没想到一个小时就完成了所有检查，还提前看上了专家号，真的太感谢董护士 了！"近日，在南京明基医院耳鼻咽喉头颈外科就诊的喉痉挛患者赵女士，对该院推出的陪诊服务赞不 绝口。 就在赵女士就诊的前一周，该院陪诊服务系统上接到一单外地患者预约陪诊服务，需要周五陪同就诊耳 鼻咽喉头颈外科于振坤院长的门诊。陪诊协调员立刻电话联系患者家属，初步评估患者就诊需求。随后 将患者需求告知耳鼻咽喉头颈外科陪诊专科护士董园园。 董园园再次与患者及家属确认就诊基本信息、对患者进行专科评估，考虑到赵女士患有喉痉挛，病情突 发风险较高，若等到预约日周五下午会耽误患者治疗。董园园立刻将患者情况反馈给于院长，出于对患 者病情的重视，于院长当即安排赵女士周三上午提前看诊。 通讯员 李娜 蒋佳佳 南京晨报/爱南京记者 孙苏静 确认后，董园园第一时间联系患者家属，耐心解释紧急协调的就诊安排。赵女士女儿因工作繁忙难以请 假，赵女士原本还在为就医事宜发愁，看到医院主动协调贴心服务，顿时卸下了心中的重担。 周三上午9：25，董园园准时在医院一站式服务中心接到赵女士，全程陪同患者完成挂号、候诊等流 程 ...

Core Insights - Qilu Hospital in Dezhou has successfully implemented a "day surgery" model for the treatment of lower limb varicose veins, allowing patients to be admitted, operated on, and discharged on the same day, marking a significant innovation in medical practice [1][2] Group 1: Innovations in Medical Practice - The "day surgery" model is supported by the hospital's pioneering "pre-admission" management system, which allows patients to complete all pre-operative checks in the outpatient setting before scheduling their surgery [1] - This new approach has drastically reduced the typical hospital stay for varicose vein surgery from nearly a week to just a few hours, enhancing patient convenience and reducing costs [1][2] Group 2: Patient Benefits and Feedback - The "pre-admission" model has served nearly 500 patients, receiving positive feedback for its time-saving, cost-effective, and stress-reducing benefits [1] - Patients can avoid bed fees, nursing fees, and treatment fees during the pre-admission period, with pre-operative examination costs eligible for insurance reimbursement after formal admission [1] Group 3: Surgical Techniques and Safety - The transition to local anesthesia from traditional spinal anesthesia has improved patient recovery times, enabling same-day discharge and ensuring safety [2] - Over the past two months, the department has successfully performed over 20 day surgeries for varicose veins under this new model [2] Group 4: Community Engagement and Future Plans - The hospital has been conducting free consultation activities for lower limb varicose veins, providing accessible platforms for patient inquiries [2] - Qilu Hospital plans to expand the range of conditions eligible for the "pre-admission" model, aiming to benefit more patients undergoing elective surgeries [2]

近日,乳山市人民医院呼吸与危重症医学科成功救治一名87岁重症肺炎合并多脏器功能衰竭的高龄患 者。在患者病情危急、治疗难度极大的情况下,医护团队凭借精湛的技术与全情的守护,不仅挽救了生命, 更以温暖细致的关怀赢得了患者家属的诚挚感谢。这背后,是一场惊心动魄的生命接力,更是一幅医患同 心、温情涌动的动人画卷。 10月30日,一位87岁老人因"痰多3小时"被紧急送往乳山市人民医院,收入呼吸与危重症医学科住院治疗。 团队经全面病情评估,诊断为重症肺炎,且合并冠心病、高血压、慢性支气管炎等多种基础疾病。患者体 内已安装心脏起搏器,血压持续偏低,团队迅速启动应急预案,制定详细的治疗方案,给予无创呼吸机辅助呼 吸、持续吸氧、持续心电监护、升压、抗感染、化痰等综合治疗,患者各项指标逐渐好转,治疗取得阶段 性成效。 在医疗技术不断进步的今天,乳山市人民医院呼吸与危重症医学科用这场成功救治再次证明:医学不仅是 科学,更是人文；医生护士不仅是治疗者,更是陪伴者与守护者。他们以技术守护生命,以温度抚慰心灵,在 平凡的岗位上,书写着不平凡的医者情怀,也为构建和谐互信的医患关系作出了生动注解。 (庄栋) 技术救治是基础,人文关怀则是治愈 ...

近日,乳山市人民医院心内二科凭借精湛医术与精准决策,成功为97岁的林奶奶(化名)实施冠状动脉球囊 扩张术,助其闯过急性心肌梗死的生死关卡。经过两周精心救治与护理,林奶奶已顺利康复出院,这一案例 刷新了该院急性心梗患者救治的最高年龄纪录。 事发当日,林奶奶因"持续性胸痛4小时"紧急就诊于乳山市人民医院。心电图检查结果瞬间拉响警报—— 急性下壁心肌梗死。作为心血管疾病中最凶险的急症之一,急性心梗的救治分秒必争,每拖延一分钟,都可 能导致更多心肌细胞不可逆坏死,对高龄患者而言,风险更是呈几何级数攀升。 一场与死神赛跑的救治随即展开。面对97岁的超高龄患者,医疗团队陷入两难抉择:传统药物治疗对急性 心梗疗效有限,难以快速开通闭塞血管；而介入手术虽能直达病灶、迅速恢复血供,但高龄患者的身体耐 受度、手术风险均远超普通患者,挑战极大。 "我们与家属进行了充分沟通,详细告知病情的紧迫性与治疗方案的利弊。"心内二科董磊主任介绍,综合 评估后发现,林奶奶虽年事已高,但日常起居基本能够自理,心脏基础功能尚可,具备介入治疗的条件。最 终,家属坚定选择信任医疗团队,同意实施手术。 当日18时,林奶奶被推入导管室。冠脉造影清晰显示,其 ...

Group 1 - The event aims to enhance operational management and internal development of medical institutions in line with the Healthy China strategy, featuring a national training program from December 18 to 21, co-hosted by Binzhou Medical University Affiliated Hospital and the Shandong Provincial Hospital Association [4] - The training program attracted over a hundred management elites from various medical and health institutions across the country to discuss management innovation and hospital development [4] - The opening speech by Wang Dong emphasized the shift in hospital management from "experience-driven" to "science-enabled," highlighting the importance of improving operational management skills and mastering scientific personnel selection methods as essential for high-quality hospital development [7] Group 2 - The training curriculum is designed to address core pain points and practical needs in hospital management, combining theoretical depth with practical application [17] - Experts delivered lectures on topics such as nuclear leadership, personnel selection, and hospital operational management, utilizing diverse formats like case studies and practical exercises to provide cutting-edge management theories and practical tools [17] - Participants from over ten cities, including key hospital leaders and management teams, found the training content directly relevant to addressing management challenges, enhancing personal leadership, and innovating hospital operational mechanisms [17] Group 3 - Binzhou Medical University Affiliated Hospital aims to continue building high-level, professional learning and exchange platforms, collaborating with national healthcare peers to deepen high-quality development paths [17]

Core Viewpoint - The Hong Kong IPO market experienced a rare event where four new stocks collectively fell below their issue prices on their first trading day, indicating a significant shift in market sentiment and performance [2][3]. Group 1: IPO Performance - Four new stocks listed on December 22, 2025, including Mingji Hospital, Impression Dahongpao, Huazai Biotechnology, and Nanhua Futures, saw declines of 49.46%, 35.28%, 29.32%, and 24.17% respectively, with Mingji Hospital's drop marking the largest first-day decline for a new stock since 2025 [2][4]. - In December 2025, out of 17 newly listed stocks, 9 experienced first-day declines, representing over 50% of the total, contrasting sharply with the strong performance of new stocks earlier in the year [3]. Group 2: Market Conditions - The overall liquidity environment in the Hong Kong market has tightened, with daily trading volumes on the Hong Kong Stock Exchange falling below 2 billion HKD, and net inflows from southbound funds significantly decreasing to 219.12 billion RMB in December [5][6]. - The Hang Seng Index, Hang Seng Tech Index, and Hang Seng China Enterprises Index all experienced declines of 1.10%, 2.82%, and 1.96% respectively during the week of December 15-19, 2025 [5]. Group 3: Factors Influencing Performance - The recent decline in new stock performance is attributed to multiple factors, including tightening liquidity, high valuations relative to fundamental performance, and regulatory changes affecting public fund holdings in Hong Kong stocks [7][8]. - Mingji Hospital's high price-to-earnings (P/E) ratio of approximately 29.8 times compared to the average P/E of 17 times for the private hospital sector in Hong Kong indicates a mismatch between valuation and fundamental performance [8][9]. Group 4: Regulatory Changes - The introduction of "Mechanism B" for IPOs allows issuers to set a lower limit on the proportion of shares available for public subscription, which can reduce the risk of mispricing but may also limit the ability of companies with high valuations to attract sufficient demand [9][10]. - Mingji Hospital utilized Mechanism B for its IPO, issuing 67 million shares with only 10% allocated for public sale, resulting in a limited float of approximately 394 million HKD [10].

通讯员 张男 患者为70多岁女性，因"胸闷、心慌10余年，加重1月"入院。心血管病二科副主任张立国详细询问病史 并结合检查发现，其24小时动态心电图显示室性早搏达38025次，占比35.4%，伴发室性心动过速29阵 共89次。患者曾于多家医院就诊，均因手术难度大、成功率不高，建议药物保守治疗。十年间症状反 复，多次住院，深受疾病困扰。得知北京安贞医院专家定期来院手术，患者为求根治，特地前来治疗。 AMC起源室性早搏是一种特殊类型的心律失常，消融靶点位于主动脉瓣与二尖瓣交界区，该区域解剖 结构复杂，导管到位困难，贴靠稳定性差，对手术标测与消融操作均构成较大挑战。术中，凭借精湛技 术与丰富经验，团队在AMC区域精准标测到最早激动点并成功实施射频消融。手术历时约1.5小时，术 后患者病情平稳，心电监护未见室性早搏，术前心律失常完全消失，心悸等症状显著缓解，患者自觉良 好，家属对治疗效果表示满意。 近日，泰安市中医医院心血管病二科成功开展首例AMC（主动脉瓣-二尖瓣交界区）起源室性心律失常 射频消融术，标志着医院在复杂心律失常介入治疗领域取得新突破，也为实现"中医特色突出、现代技 术卓越、综合实力雄厚、服务品质优良" ...

Core Viewpoint - The article highlights the efforts of the Daiyue District Planning Service Center in Tai'an to expedite the planning and construction of a Chinese and Western medicine hospital project, aiming to enhance regional public service levels and healthcare resources [1] Group 1: Project Overview - The hospital project is planned to cover an area of 4.99 hectares, located in the Daiyue Economic Development Zone, north of Tai Fei First Road and west of Jinniu Mountain Road [1] - Upon completion, the project will improve the allocation of medical resources in the region and provide high-quality integrated medical services to the public [1] Group 2: Planning and Coordination Efforts - The Planning Service Center has actively engaged with the hospital construction team and project management departments to ensure alignment on planning technical specifications and architectural design standards [1] - The center is closely monitoring the progress of preliminary work such as soil pollution investigations, cultural heritage assessments, and traffic impact analyses, ensuring that detailed planning is advanced in tandem [1] Group 3: Support and Services - The center provides "one-on-one" tracking services to address challenges related to land and planning, thereby saving valuable time for the project's implementation [1] - The control detailed planning for the project has already been approved by the municipal government, and the center plans to offer comprehensive support in policy consultation, technical guidance, and approval coordination to facilitate high-standard and efficient project execution [1]